Checkpoint Therapeutics, Inc.

NASDAQ:CKPT

2.46 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Revenue 0.1030.1920.2681.0691.7083.5061.7252.570.59
Cost of Revenue 43.56649.82548.45316.35219.32533.65419.08120.26711.323
Gross Profit -43.463-49.633-48.185-15.283-17.617-30.148-17.356-17.697-10.733
Gross Profit Ratio -421.971-258.505-179.795-14.297-10.314-8.599-10.061-6.886-18.192
Reseach & Development Expenses 43.56649.82548.45316.35219.32533.65419.08120.26711.323
General & Administrative Expenses 8.6858.78.5387.9187.2336.5925.4194.4672.488
Selling & Marketing Expenses 0.30.40000000
SG&A 8.6858.78.5387.9187.2336.5925.4194.4672.488
Other Expenses 000000.225000
Operating Expenses 52.25158.52556.99124.2726.55840.24624.524.73413.811
Operating Income -52.148-58.333-56.723-23.201-24.85-36.74-22.775-22.164-13.221
Operating Income Ratio -506.291-303.818-211.653-21.703-14.549-10.479-13.203-8.624-22.408
Total Other Income Expenses Net 0.301-4.2910.0530.120.1360.2250.098-0.297-0.438
Income Before Tax -51.847-62.624-56.67-23.081-24.714-36.367-22.677-22.461-13.892
Income Before Tax Ratio -503.369-326.167-211.455-21.591-14.47-10.373-13.146-8.74-23.546
Income Tax Expense -0.1684.291-0.053-0.12-0.136-0.521-22.677-22.1170.233
Net Income -51.847-66.915-56.617-22.961-24.578-36.367-22.677-22.461-13.892
Net Income Ratio -503.369-348.516-211.257-21.479-14.39-10.373-13.146-8.74-23.546
EPS -2.77-7.57-7.45-4.11-6.96-12.74-10.03-10.43-5.69
EPS Diluted -2.77-7.57-7.45-4.11-6.96-12.74-10.03-10.43-5.69
EBITDA -52.148-53.882-56.723-23.201-24.85-36.74-22.677-22.117-13.219
EBITDA Ratio -506.291-280.635-211.653-21.703-14.549-10.479-13.146-8.606-22.405